Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies

Published:2010-03-28 Issue:5 Volume:29 Page:971-977
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Galatin Peter S.,Advani Ranjana H.,Fisher George A.,Francisco Brian,Julian Thomas,Losa Raquel,Sierra Marta I.,Sikic Branimir I.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-010-9416-4.pdf

Reference48 articles.

1. Zimmerman KC, Green DR (2001) How cells die: apoptosis pathways. J Allergy Clin Immunol 108:S99–S103

2. Korsmeyer SJ et al (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4:327–332

3. Koty PP et al (2002) In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions. Lung Cancer 35:155–163

4. Grizzle WE et al (2002) Molecular staging of colorectal cancer in African – American and Caucasian patients using phenotypic expression of p53, bcl-2, MUC-1 AND p27 (kip-1). Intl J Cancer 97:403–409

5. Scopa CD, Vagianos C, Kardamakis D et al (2001) Bcl-2/Bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. Appl Immunohistochem Mol Morphol 9(4):329–334

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial Outcomes of Cancer Therapeutic Modalities Based on Targeting Apoptosis;Current Drug Targets;2022-08

2. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer;Cells;2020-05-21

3. Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review;BioMed Research International;2019-09-29

4. Structural optimization and additional targets identification of antisense oligonucleotide G3139 encapsulated in a neutral cytidinyl-lipid combined with a cationic lipid in vitro and in vivo;Biomaterials;2019-03

5. Targeting the Bcl-2 Family in B Cell Lymphoma;Frontiers in Oncology;2019-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3